Related Experiment Videos
Persistent megaloblastic anemia: a diagnostic dilemma
Southern Medical Journal
|March 1, 1981
Summary
Sickle cell trait with pernicious anemia can mimic sickle thalassemia due to elevated HbA2 and abnormal red blood cells. Vitamin B12 corrects the condition, confirming pernicious anemia.
Area of Science:
- Hematology
- Medical Diagnostics
- Genetics
Background:
- Sickle cell trait (SCT) and pernicious anemia (PA) are distinct hematologic conditions.
- PA is an autoimmune disorder causing vitamin B12 deficiency and megaloblastic anemia.
- SCT is a genetic condition affecting hemoglobin structure.
Observation:
- Patients with concurrent SCT and PA in relapse may present with overlapping hematologic findings.
- Elevated hemoglobin A2 (HbA2) levels can be observed in both conditions.
- Peripheral blood smears may show target cells, teardrop cells, and elliptocytes, complicating differential diagnosis.
Findings:
- Distinguishing between SCT with PA and sickle thalassemia requires careful diagnostic evaluation.
- A normal hemoglobin alpha:beta chain ratio is indicative of PA, not thalassemia.
- Megaloblastic bone marrow morphology and hematologic improvement after vitamin B12 administration confirm PA.
Implications:
- Accurate diagnosis is crucial for appropriate treatment and patient management.
- Misdiagnosis can lead to ineffective or incorrect therapies.
- Understanding these overlapping presentations improves diagnostic accuracy in hematology.